Search

Author/Creator Valeyre, D

1. AB0007 Shared genetic predisposition in rheumatoid arthritis–interstitial lung disease and familial pulmonary fibrosis. (15th June 2017)

Authors:
Juge, PA; Borie, R; Kannengiesser, C; Gazal, S; Revy, P; Wemeau-Stervinou, L; Debray, MP; Ottaviani, S; Marchand-Adam, S; Nathan, N; Thabut, G; Richez, C; Nunes, H; Callebaut, I; Justet, A; Richette, P; Lioté, H; Allanore, Y; Sand, O; Dromer, C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
1049
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P13 Safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): Integrated analysis of cumulative data from 5 clinical trials. (12th November 2015)

Authors:
Noble, PW; Albera, C; Bradford, WZ; Costabel, U; Glaspole, I; Glassberg, MK; Lederer, DJ; Lin, Z; Nathan, SD; Pereira, CA; Swigris, JJ; Valeyre, D; Lancaster, L
Journal:
Thorax
Issue:
Volume 70(2015)Supplement 3
Page Start:
A80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P14 Pirfenidone is efficacious in patients with idiopathic pulmonary fibrosis (IPF) with more preserved lung function. (12th November 2015)

Authors:
Noble, PW; Bradford, WZ; Costabel, U; Glaspole, I; Glassberg, MK; Gorina, E; Kardatzke, D; Lancaster, L; Lederer, DJ; Nathan, SD; Pereira, C; Spirig, D; Swigris, JJ; Valeyre, D; Albera, C
Journal:
Thorax
Issue:
Volume 70(2015)Supplement 3
Page Start:
A81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗